LEXX.US Lexaria Bioscience Corp

Healthcare Biotechnology USA Stocks
4.44 USD
Close of Nov 15, 2026
2.43 21.60
Market cap
USD 9.35M
P/E
-
P/B
1.97x
ROE
-141.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to May 2026.

Is LEXX.US undervalued?

Graham number

The Graham number of Lexaria Bioscience Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Lexaria Bioscience Corp fundamental analysis

No fundamental analysis for Lexaria Bioscience Corp yet.

Lexaria Bioscience Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Lexaria Bioscience Corp

Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerability while promoting healthier oral ingestion method…

Full company profile